Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer
Open Access
- 1 August 2017
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 3 (8) , e172032
Abstract
Non–small cell lung cancer (NSCLC) is a major health burden worldwide; importantly, both the disease—as well as its treatment—can cause symptomatic deterioration. In unresectable locally advanced disease, concurrent chemoradiotherapy (CRT) is recommended, but patients often find it difficult to tolerate because they frequently have comorbidities and suboptimal performance status.1,2Keywords
This publication has 21 references indexed in Scilit:
- Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non–Small Cell Lung CancerJournal of Thoracic Oncology, 2017
- Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical TrialJournal of Clinical Oncology, 2017
- Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non–Small Cell Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
- A systematic review of the cost and cost‐effectiveness studies of proton radiotherapyCancer, 2016
- Radiotherapy dose and fractionation for stage III NSCLCThe Lancet Oncology, 2015
- Clinical Implementation of Intensity Modulated Proton Therapy for Thoracic MalignanciesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Long-Term Clinical Outcome of Intensity-Modulated Radiotherapy for Inoperable Non-Small Cell Lung Cancer: The MD Anderson ExperienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410JNCI: Journal of the National Cancer Institute, 2011
- Initial Evaluation of Treatment-Related Pneumonitis in Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Concurrent Chemotherapy and Intensity-Modulated RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non–small-cell lung cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006